Form 4: IAS Chief Accounting Officer Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 25,901 shares of common stock for a weighted average price of $10.18 per share under a pre-arranged trading plan.
Summary
- Alexis Gil II, Chief Accounting Officer of Integral Ad Science Holding Corp. (IAS), reported a sale of company common stock.
- The transaction involved the disposition of 25,901 shares of common stock.
- The shares were sold on September 24, 2025, at a weighted average price of $10.18 per share, with prices ranging from $10.18 to $10.20.
- The sale was executed under a Rule 10b5-1 trading plan adopted on June 12, 2025.
- Following this transaction, Gil Alexis II directly beneficially owns 145,140 shares of Integral Ad Science Holding Corp. common stock.
Sentiment
Score: 5
Explanation: The filing is a standard Form 4 disclosing an insider stock sale executed under a pre-established 10b5-1 trading plan. This is a common practice for personal financial planning and is generally considered neutral in terms of immediate market sentiment.
Future Outlook
This filing, a Form 4, does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report is specific to an individual's stock activity and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The sale by a Chief Accounting Officer, even under a 10b5-1 plan, slightly reduces insider ownership. While pre-planned, some investors may monitor insider selling activity.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 09/24/2025 | Date of earliest transaction (sale of common stock). |
| 09/26/2025 | Signature date of the Form 4 filing. |
Recommendation
holdThe filing details a routine insider stock sale by the Chief Accounting Officer under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial planning and do not usually indicate a change in the company's fundamental outlook or warrant a strong buy/sell recommendation based solely on this disclosure. Investors should consider broader company performance and market conditions.
Keywords
Integral Ad Science, IAS, Alexis Gil II, Chief Accounting Officer, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.